发明申请
- 专利标题: HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF
- 专利标题(中): 异氟醚化合物作为BTK抑制剂及其用途
-
申请号: US15029420申请日: 2014-10-21
-
公开(公告)号: US20160264548A1公开(公告)日: 2016-09-15
- 发明人: Hui QIU , Richard D. CALDWELL , Constantin NEAGU , Igor MOCHALKIN , Lesley LIU-BUJALSKI , Reinaldo JONES , Devon TATE , Theresa L. JOHNSON , Anna GARDBERG
- 申请人: Hui QIU , Richard D. CALDWELL , Constantin NEAGU , Igor MOCHALKIN , Lesley LIUBUJALSKI , Reinaldo JONES , Devon TATE , Theresa L. JOHNSON , Anna GARDBERG , MERCK PATENT GMBH
- 申请人地址: DE Darnstadt
- 专利权人: Merck Patent GMBH
- 当前专利权人: Merck Patent GMBH
- 当前专利权人地址: DE Darnstadt
- 国际申请: PCT/US14/61455 WO 20141021
- 主分类号: C07D401/04
- IPC分类号: C07D401/04 ; C07D401/14 ; C07D409/04 ; C07D405/04 ; C07D413/14 ; C07D401/12 ; C07D403/12 ; C07D403/04 ; C07D405/14 ; C07D495/04 ; C07D239/47 ; C07F5/02 ; C07D487/08 ; C07D487/10 ; C07D487/04 ; C07D239/48 ; C07D471/08 ; C07D451/02 ; C07D213/82
摘要:
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
公开/授权文献
- US10329270B2 Heteroaryl compounds as BTK inhibitors and uses thereof 公开/授权日:2019-06-25